Biosimilars and Biologics Market Growth, Trends & Forecast 2025 | Top key players - Amgen Inc., Johnson & Johnson, Biogen Inc.

The Biosimilars and Biologics Market size reached US$ 531.45 Billion in 2024 and is expected to reach US$ 1,773.77 Billion by 2033, growing at a CAGR of 14.4% during the forecast period 2025-2033.

The Biosimilars and Biologics Market, as examined in the DataM Intelligence study, offers a comprehensive overview of the industry, enriched with in-depth insights, historical data, and key statistics. The report provides a thorough analysis of market dynamics, competitive strategies, and leading players, detailing their product offerings, pricing models, financial performance, expansion strategies, and regional presence.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID) @ https://datamintelligence.com/download-sample/biosimilars-and-biologics-market?sz

The Biosimilars and Biologics Market involves the development and sale of complex, life-saving medicines made from living organisms. Biologics are original, innovative therapies, while biosimilars are highly similar, more affordable versions. This market plays a crucial role in improving patient access to advanced treatments for conditions like cancer, autoimmune diseases, and more, driving healthcare innovation and cost savings globally.

Key Development

In March 2025, Fresenius announced a major milestone for its subsidiary Fresenius Kabi: the U.S. Food and Drug Administration (FDA) approved the Biologics License Application (BLA) for two of their denosumab biosimilars, Conexxence and Bomyntra. These biosimilars are cleared for the same uses as the original reference drugs, Prolia and Xgeva, respectively, offering more options for patients and healthcare providers.

In March 2025, Celltrion celebrated FDA approval of OMLYCLO, the first and only biosimilar to be officially designated as interchangeable with XOLAIR. OMLYCLO is approved to treat a range of conditions, including moderate to severe persistent asthma, chronic rhinosinusitis with nasal polyps, IgE-mediated food allergies, and chronic spontaneous urticaria, expanding access to this important therapy.

Major Players Shaping the Biosimilars and Biologics Market:

The prominent players in Biosimilars and Biologics market research report are: Amgen Inc., Johnson & Johnson, Biogen Inc., Teva Pharmaceutical Industries Limited, Biocon Biologics Inc., Pfizer Inc., Celltrion, Inc., Samsung Bioepis, AbbVie Inc., Boehringer Ingelheim International GmbH, and among others.

The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.

Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/biosimilars-and-biologics-market

Market Segments

By Type: Biologics, Biosimilars.

By Application: Oncology, Autoimmune Diseases, Chronic Diseases, Infectious Diseases, Neurology, Ophthalmology, Others.

The Biosimilars and Biologics industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.

Regions Covered:

The global Biosimilars and Biologics Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.

☞ North America - US, Canada, Mexico

☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe

☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific

☞ South America- Brazil, Argentina, Colombia, Rest of South America

☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.